p-fin4 is a peptide inhibitor targeting the interaction between STEP Phosphatase and GluA2 AMPA receptor, exhibiting a Ki of 0.4 μM. This compound has been shown to reverse memory deficits and exert anxiolytic and antidepressant effects in scopolamine-treated rats, suggesting its potential as a lead compound for developing novel cognitive enhancers and behavioral modulators [1].